Zobrazeno 1 - 10
of 72
pro vyhledávání: '"A. G. Selezneva"'
Autor:
O. A. Lobovikova, I. V. Shul'gina, E. G. Abramova, A. K. Nikiforov, A. V. Komissarov, V. A. Demchenko, A. G. Selezneva, A. S. Fes'kova, S. S. Galetova, N. P. Mironova
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 8, Iss 1, Pp 92-96 (2019)
Introduction. Documentation is an integral part of the quality management system, a key element of production and quality control of medicines. A necessary condition for the Rules of good manufacturing practice and guaranteed production of quality pr
Externí odkaz:
https://doaj.org/article/e2b5b9429fef4aabbb3d8f14e5d50811
Autor:
E. G. Abramova, A. K. Nikiforov, M. N. Kireev, N. N. Kochkalova, S. V. Generalov, A. G. Selezneva, L. V. Savitskaya, Yu. V. Ivanov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4(106), Pp 54-57 (2010)
Presented are the data of analysis of molecular parameters of heterologous immunoglobulin produced by the Russian Research Anti-Plague Institute "Microbe". It is noted that the optimal system of rectification enables to obtain a preparation composed
Externí odkaz:
https://doaj.org/article/17374476976d47e8915f62fd40e4888e
Autor:
E. G. Abramova, A. K. Nikiforov, O. A. Lobovikova, S. A. Eremin, Yu. G. Vasin, T. A. Mikheeva, I. M. Zhulidov, L. N. Minaeva, M. V. Galkina, L. V. Savitskaya, A. G. Selezneva, R. A. Svintsov, S. V. Generalov, I. V. Shoulgina
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3(105), Pp 58-62 (2010)
Presented are the comparative data of actual and regulated indicators of the qualitative characteristics of the heterologous anti-rabies immunoglobulin produced by the RARI Microbe for the five years of serial preparation manufacturing. Modern high-t
Externí odkaz:
https://doaj.org/article/dc1f3a625dac4be88c74a58b132b79e8
Publikováno v:
Meditsinskiy sovet = Medical Council. :131-138
Introduction. Patients with hormone-receptor-positive (HR+) breast cancer (BC) over 40 years old who take tamoxifen are not subject to mandatory castration. However this cohort of patients is not homogeneous.Aim. The present study is aimed at studyin
Autor:
Irina G. Selezneva, Anna S. Suhova
Publikováno v:
PRIMO ASPECTU. :88-92
This article analyzes the effectiveness of test methods in legal education of students, reveals the specifics of the impact of test technologies on the activation of educational potential in distance learning and the development of knowledge control
Autor:
A.V. Razzhivin, R. A. Svintsov, A. G. Selezneva, E. G. Abramova, E.A. Usachev, O.V. Gorbunova, I. M. Zhulidov
Publikováno v:
"Veterinary Medicine" Journal. 23:03-09
Autor:
V. A. Chadaev, K. Yu. Mukhin, L. G. Selezneva, S. R. Nurmukhametova, A. A. Alikhanov, O. V. Mendelevich, I. G. Vasilyev, L. Yu. Glukhova, M. S. Nikitina, O. A. Pylaeva
Publikováno v:
Russkij Žurnal Detskoj Nevrologii, Vol 13, Iss 4, Pp 64-69 (2019)
This article provides a detailed description of clinical and electroanatomical characteristics of epilepsy in patients suffering from epileptic trances – a rare type of focal motor seizures with ambulatory automatism manifesting as an unplanned tra
Autor:
Svetlana Yu Filippova, Oleg I. Kit, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Sergey V. Tumanyan, Nina M. Abdullaeva, Oksana E. Zhenilo, Olga G. Selezneva, Natalia V. Chernikova, Anna Yu Ardzha, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15003-e15003
e15003 Background: Taxanes and platinum compounds are widely used in cervical cancer chemotherapy. In particular, a combination of 75 mg/m2cisplatin and 175 mg/m2 paclitaxel, which suggests a doses ratio of 1:2.3, is recommended as first-line systemi
Autor:
Anastasia O. Sitkovskaya, Oleg I. Kit, Svetlana Yu Filippova, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Anna A. Cherkasova, Polina A. Kruze, Yuriy A. Poryvaev, Natalia V. Chernikova, Olga G. Selezneva, Meri L. Adamyan, Olga N. Guskova
Publikováno v:
Journal of Clinical Oncology. 40:e15002-e15002
e15002 Background: Bleomycin is a glycopeptide antibiotic with anticancer properties. Clinical data indicate a relatively low efficacy of bleomycin in mono regimen, which is also accompanied by side effects from high doses. That’s why so it is more
Autor:
Natalia N. Tsaplina, Natalya V. Porkhanova, Natalya B. Fatkina, Mikhail S. Zinkovich, Marina A. Gusareva, Anna A. Solntseva, Ekaterina O. Vasilieva, Natalia G Kosheleva, Ekaterina A. Tolmacheva, Ksenia V. Martynova, Irina A. Udalenkova, Lyudmila Ya Rozenko, Olga G. Selezneva, Alla V. Pustovalova, Tatiana G. Chalabova, Olga V. Shlyakhova, Pavel N. Meshcheryakov, Sergey V. Oskin, Oleg I. Kit, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e17512-e17512
e17512 Background: Cervical cancer (CC) is one of the most common cancers in women worldwide (4th in frequency). Traditionally, radical hysterectomy or radiation therapy (RT) is used as the standard treatment for early-stage CC, and locally advanced